Gapping upSeveral large cap pharma names are higher premarket: NVS +1.6%, GSK +1%, MYL +1.1% (launches generic version of Watson's Zovia; launches generic version of Pfizer's Cerebyx injection) .
Metals & Mining ETFs/stocks trading higher: AU +2.6%, AUY +2.2%, NG +1.8%, GOLD +1.4%, VALE +1.4%, SLW +1.4%, GG +1.3%, ABX +0.9%, AG +0.9%, BBL +0.9%, GDX +0.8%, GLD +0.4%, SLV +0.3%
A few beverage related names are seeing early strength: BUD +1%, DEO +1%, KO (ticking higher)
Other news:
- FBIO +44.1% (MB-101 for the treatment of glioblastoma was highlighted in the New England Journal of Medicine)
- ETRM +16.5% (higher on light volume after announcing the retirement of all senior convertible notes)
- SHLD +6.4% (obtained a secured standby letter of credit facility)
- PBMD +3.6% (announced first clinical data from combination of IMP321 with ANTI-PD1; Database Safety Monitoring Board confirmed that IMP321 is safe and well tolerated)
- SDRL +2.3% (announces a 3-year year contract extension for jack-up AOD III; will add will add ~$112.5 mln in contract backlog)
- PHH +1.5% and NRZ +0.4% (PHH Corp to sell entire portfolio of mortgage servicing rights to New Residential Investment-excluding the Ginnie Mae)
- MBLY +1.5% (HERE and Mobileye to partner on REM and Open Location Platform technology to enable crowd-sourced HD mapping for automated driving)
- VOD +1.2%, QGEN +1.2%, PSO +1.2%, SNN +0.8% (still checking)
- BP +1.1% (BP and PTT Public Limited Company entered into a sales and purchase agreement for liquefied natural gas)
- GALE +0.8% (following 20%+ move higher yesterday),
- S +0.3% (very light volume-- confirmed plans to create or bring back to America 5,000 jobs)
Analyst comments:
- SNH +6.1% (Senior Housing initiated with an Overweight at Cantor; tgt $23)